Portfolio
2
companies
Travel AI
Travel AI develops transportation software for travel personalisation and context awareness.
Videregen
Videregen develops biological scaffolds for organ replacement and regenerative medicine.
The Liverpool-based stem cell specialist raised the funds from founders, angels, and Spark Impact to scale manufacturing and run clinical trials.
"I am delighted to have secured our initial investment which will leverage our TSB grant. The investment will allow us to formally demonstrate our world-leading technology platform in a scientifically and clinically rigorous way, moving it further towards commercial reality. Sincere thanks to all of our investors for their support."
The angel round was anchored by London Business Angels and an LBA syndicate.
"We’re delighted with the calibre of angels we have recruited to join the team. Bringing with them sector, founder and exit experiences to help us move faster. The next few months offer us opportunities to grow our profile, launch product and extend our understanding of the market. So the team are very excited to be at the vanguard of context sensing and look forward to solving real world business problems while generating new insight in the movement of people and goods."
